Market Currents
Eli Lilly (LLY) may have jumped 5.3% yesterday and added $3B to its market cap following news...
-
Tuesday, October 9, 2012, 9:33 AM ETEli Lilly (LLY) may have jumped 5.3% yesterday and added $3B to its market cap following news that its Solanezumab drug helped slow the progress of Alzheimer's Disease in Phase III trials, but SA author Brian Wilson points out that "the results were not statistically significant." This means that the study can't be used for an NDA submission of solanezumab, which is therefore "not going to make it to...market."
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: